1. Academic Validation
  2. Identification of a Dutch founder mutation in MUSK causing fetal akinesia deformation sequence

Identification of a Dutch founder mutation in MUSK causing fetal akinesia deformation sequence

  • Eur J Hum Genet. 2015 Sep;23(9):1151-7. doi: 10.1038/ejhg.2014.273.
M Brigita Tan-Sindhunata 1 Inge B Mathijssen 2 Margriet Smit 1 Frank Baas 3 Johanna I de Vries 4 J Patrick van der Voorn 5 Irma Kluijt 2 Marleen A Hagen 4 Eveline W Blom 6 Erik Sistermans 1 Hanne Meijers-Heijboer 7 Quinten Waisfisz 1 Marjan M Weiss 1 Alexander J Groffen 8
Affiliations

Affiliations

  • 1 Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
  • 2 Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands.
  • 3 Department of Genome Analysis, Academic Medical Center, Amsterdam, The Netherlands.
  • 4 Department of Obstetrics and Gynaecology, Research Institute MOVE, VU University Medical Center, Amsterdam, The Netherlands.
  • 5 Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
  • 6 Department of Clinical Genetics, MUMC, Maastricht, The Netherlands.
  • 7 1] Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands [2] Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands.
  • 8 1] Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands [2] Department of Functional Genomics, Center for Neurogenomics and Cognition Research, VU University, Amsterdam, The Netherlands.
Abstract

Fetal akinesia deformation sequence (FADS) refers to a clinically and genetically heterogeneous group of disorders with congenital malformations related to impaired fetal movement. FADS can result from mutations in CHRNG, CHRNA1, CHRND, DOK7 and RAPSN; however, these genes only account for a minority of cases. Here we identify MUSK as a novel cause of lethal FADS. Fourteen affected fetuses from a Dutch genetic isolate were traced back to common ancestors 11 generations ago. Homozygosity mapping in two fetuses revealed MUSK as a candidate gene. All tested cases carried an identical homozygous variant c.1724T>C; p.(Ile575Thr) in the intracellular domain of MUSK. The carrier frequency in the genetic isolate was 8%, exclusively found in heterozygous carriers. Consistent with the established role of MUSK as a tyrosine kinase that orchestrates neuromuscular synaptogenesis, the fetal myopathy was accompanied by impaired acetylcholine receptor clustering and reduced tyrosine kinase activity at motor nerve endings. A functional assay in myocytes derived from human fetuses confirmed that the variant blocks MUSK-dependent motor endplate formation. Taken together, the results strongly support a causal role of this founder mutation in MUSK, further expanding the gene set associated with FADS and offering new opportunities for prenatal genetic testing.

Figures